University of Alberta
Edmonton, Alberta, Canada
40 recruiting
Showing 1–20 of 103 trials
Recruiting
Phase 2
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
Primary Biliary CholangitisPBC
Mirum Pharmaceuticals, Inc.260 enrolled130 locationsNCT05050136
Recruiting
Phase 1Phase 2
A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL
B Cell Precursor Acute Lymphoblastic Leukemia
Amgen281 enrolled109 locationsNCT04521231
Recruiting
Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Primary Biliary Cholangitis
Gilead Sciences318 enrolled196 locationsNCT06051617
Recruiting
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
Huntington Disease
Hoffmann-La Roche600 enrolled45 locationsNCT06667414
Recruiting
International Severe Asthma Registry: Canadian Cohort
Severe Asthma
University of British Columbia714 enrolled12 locationsNCT04045587
Recruiting
Not Applicable
Prebiotics in Patients With Type 1 Diabetes
Type 1 Diabetes
University of Calgary144 enrolled3 locationsNCT04963777
Recruiting
Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection RecurrenceClostridium DifficileClostridioides Difficile Infection+7 more
Vedanta Biosciences, Inc.852 enrolled215 locationsNCT06237452
Recruiting
Phase 3
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Invasive Mold Infections
Basilea Pharmaceutica234 enrolled49 locationsNCT06925321
Recruiting
Not Applicable
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Heart FailureCardiovascular DiseasesHeart Diseases+3 more
Cardiac Dimensions, Inc.300 enrolled92 locationsNCT03142152
Recruiting
Phase 2Phase 3
Transcutaneous Spinal Cord Stimulation for Upper Extremity Function
StrokeSpinal Cord Injuries
University of Alberta30 enrolled2 locationsNCT06596369
Recruiting
Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisProgressive Muscular Atrophy+1 more
University of Alberta150 enrolled4 locationsNCT05204017
Recruiting
GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain
Low Back Pain
University of Alberta2,200 enrolled1 locationNCT06924671
Recruiting
Phase 2
An Adaptive Design Study of MTX228
Type 1 Diabetes Mellitus
University of Alberta24 enrolled1 locationNCT06474598
Recruiting
Not Applicable
Study in Parkinson Disease of Exercise
Parkinson Disease
Northwestern University370 enrolled25 locationsNCT04284436
Recruiting
Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
Prostate Cancer Screening
University of Alberta1,284 enrolled6 locationsNCT06626022
Recruiting
Phase 2
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
Eosinophilic Granulomatosis With PolyangiitisChurg-Strauss Syndrome
NS Pharma, Inc.45 enrolled34 locationsNCT06046222
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Multiple MyelomaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+1 more
Sumitomo Pharma America, Inc.606 enrolled104 locationsNCT04988555
Recruiting
Phase 3
Study of Bitopertin in Participants With EPP or XLP (APOLLO)
Erythropoietic Protoporphyria (EPP)X-Linked Protoporphyria (XLP)
Disc Medicine, Inc150 enrolled28 locationsNCT06910358
Recruiting
Not Applicable
Upper Airway's Pressure Drop Analyses After Mandibular Advancement and Maxillary Expansion
ApneaAirway Obstruction, NasalMandible Small+1 more
University of Alberta90 enrolled1 locationNCT04190953
Recruiting
Phase 2
Antibiotic Prophylaxis for Neurogenic Bladder Botox
Neurogenic BladderPost-operative Urinary Tract Infections
University of Alberta160 enrolled1 locationNCT04791579